|
| 37768207 | Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester. | Clin Infect Dis | 2024 |
| 36272499 | Mitochondrial redox environments predict sensorimotor brain-behavior dynamics in adults with HIV. | Brain Behav Immun | 2023 |
| 37604474 | Preferences of Patients and Providers in High-Burden Malaria Settings for Long-Acting Malaria Chemoprevention. | Am J Trop Med Hyg | 2023 |
| 35855581 | Convergent and divergent oscillatory aberrations during visuospatial processing in HIV-related cognitive impairment and Alzheimer's disease. | Cereb Cortex | 2023 |
| 37072885 | Zinc and Coronavirus Disease 2019. | Clin Infect Dis | 2023 |
| 37227925 | 1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis. | Clin Infect Dis | 2023 |
| 36853100 | The cascade of care for household contacts of people with drug-resistant TB. | Int J Tuberc Lung Dis | 2023 |
| 36910693 | Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study. | Open Forum Infect Dis | 2023 |
| 36930628 | Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household. | PLoS One | 2023 |
| 36660819 | Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study. | Clin Infect Dis | 2023 |
| 36041016 | Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349). | Clin Infect Dis | 2023 |
| 34261093 | Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment. | AIDS | 2022 |
| 35678468 | Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis. | J Antimicrob Chemother | 2022 |
| 35813878 | Signatures of somatosensory cortical dysfunction in Alzheimer's disease and HIV-associated neurocognitive disorder. | Brain Commun | 2022 |
| 36410384 | Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment. | Clin Infect Dis | 2022 |
| 36410382 | What Clinicians Need to Know About the Development of Long-Acting Formulations. | Clin Infect Dis | 2022 |
| 36163664 | Caregiver willingness to give TPT to children living with drug-resistant TB patients. | Int J Tuberc Lung Dis | 2022 |
| 36346703 | Update on tuberculosis/HIV coinfections: across the spectrum from latent infection through drug-susceptible and drug-resistant disease. | Top Antivir Med | 2022 |
| 35943252 | Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing. | Antimicrob Agents Chemother | 2022 |
| 34918028 | Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine. | Clin Infect Dis | 2022 |
| 35239624 | High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis. | Pediatr Infect Dis J | 2022 |
| 34699587 | Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments. | Clin Infect Dis | 2022 |
| 34800394 | Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. | Lancet Infect Dis | 2022 |
| 32408771 | Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection. | AIDS Care | 2021 |
| 33743684 | Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials. | BMC Health Serv Res | 2021 |
| 33627075 | Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial. | BMC Infect Dis | 2021 |
| 33738895 | Impact of HIV-infection on human somatosensory processing, spontaneous cortical activity, and cortical thickness: A multimodal neuroimaging approach. | Hum Brain Mapp | 2021 |
| 33902356 | The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data? | J Int Assoc Provid AIDS Care | 2021 |
| 33822880 | Reductions in Gray Matter Linked to Epigenetic HIV-Associated Accelerated Aging. | Cereb Cortex | 2021 |
| 33762075 | A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB. | Int J Tuberc Lung Dis | 2021 |
| 33772550 | Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study. | Clin Infect Dis | 2021 |
| 34464488 | Cannabis use impacts pre-stimulus neural activity in the visual cortices of people with HIV. | Hum Brain Mapp | 2021 |
| 34403326 | A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial. | Am J Respir Crit Care Med | 2021 |
| 34375884 | Gray matter volumes discriminate cognitively impaired and unimpaired people with HIV. | Neuroimage Clin | 2021 |
| 34476989 | A Midwestern Academic HIV Clinic Operation during the COVID-19 Pandemic: Implementation Strategy and Preliminary Outcomes. | J Int Assoc Provid AIDS Care | 2021 |
| 34056699 | Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8Â Weeks (ATLAS-2M). | Patient | 2021 |
| 33951360 | Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. | N Engl J Med | 2021 |
| 34280780 | Neuroinflammatory profiles regulated by the redox environment predicted cognitive dysfunction in people living with HIV: A cross-sectional study. | EBioMedicine | 2021 |
| 33166693 | Long-acting drugs and formulations for the treatment and prevention of HIV infection. | Int J Antimicrob Agents | 2021 |
| 33308425 | Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. | Lancet | 2021 |
| 32845985 | Neighborhood Deprivation and Racial/Ethnic Disparities in Human Immunodeficiency Virus Viral Suppression: A Single-center, Cross-sectional Study in the United States Midwest. | Clin Infect Dis | 2021 |
| 32815870 | Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine. | Pharmacogenet Genomics | 2021 |
| 32436478 | "I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain. | Cult Health Sex | 2021 |
| 30942853 | Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease. | Clin Infect Dis | 2020 |
| 33834177 | Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial. | Lancet Microbe | 2020 |
| 31873746 | Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults. | J Antimicrob Chemother | 2020 |
| 32099845 | Response to Dong et al. | Open Forum Infect Dis | 2020 |
| 31981713 | High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. | Contemp Clin Trials | 2020 |
| 31913556 | New opportunities in tuberculosis prevention: implications for people living with HIV. | J Int AIDS Soc | 2020 |
| 32102916 | Age-related visual dynamics in HIV-infected adults with cognitive impairment. | Neurol Neuroimmunol Neuroinflamm | 2020 |